Article
EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF
21 Jan 2013
Abstract excerpt
Understanding tumor-induced angiogenesis is a challenging problem with important consequences for the diagnosis and treatment of cancer. In this study, we define a novel function for epithelial membrane protein-2 (EMP2) in the control of angiogenesis. EMP2 functions as an oncogene in endometrial cancer, and its expression has been linked to decreased survival. Using endometrial cancer xenografts, modulation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
